Mechanistically, TIM-3 and its ligand Gal-9 promotes activation of canonical Wnt/β-catenin pathway, enhancing CSC self-renewal and maintenance in AML [129, 284]. The gene discussed is HAVCR2; the disease is acute myeloid leukemia.